ProMIS Neurosciences Inc. is trading 5.7% up today at $10.30, extending its recovery from last week’s sharp swings and a 6.17% decline on June 5.
- The move appears to be a technical, flow-driven bounce, as there are no new company-specific headlines, regulatory filings, earnings releases, or analyst rating changes tied to the price action.
- Today’s strength suggests a technical rerating rather than news-driven momentum, particularly as broader U.S. indices are trading lower.